
Wegovy maker Novo Nordisk cuts profit forecast as US prescriptions tail off
Denmark’s Novo Nordisk has cut its annual revenue and profit forecasts after disappointingly “flabby” sales of its weight loss drug Wegovy, as US prescriptions tailed off amid fierce competition. A boom in sales of Wegovy and the diabetes medication …